plays an important role in cartilage extracellular matrix degradation and bone resorption in OA (osteoarthritis) through the induction of degradative enzymes and proinflammatory mediators. In the present study, we have determined the consequences of HO-1 (haem oxygenase-1) induction on markers of inflammation and senescence in the functional unit cartilage-subchondral bone stimulated with IL-1β. Cartilage-subchondral bone specimens were obtained from the knees of osteoarthritic patients. Treatment with the HO-1 inducer CoPP (cobalt protoporphyrin IX) counteracted the stimulatory effects of IL-1β on IL-6, nitrite, PGE 2 (prostaglandin E 2 ), TGF (transforming growth factor) β 2 , TGFβ 3 and osteocalcin. Immunohistochemical analyses indicated that CoPP treatment of explants downregulated iNOS (inducible nitric oxide synthase), COX-2 (cyclooxygenase-2) and mPGES-1 (microsomal prostaglandin E synthase-1) induced by IL-1β. In contrast, the expression of HMGB1 (high-mobility group box 1) was not significantly modified. In addition, CoPP decreased the expression of iNOS and mPGES-1 in cells isolated from the explants and stimulated with IL-1β, which was counteracted by an siRNA (small interfering RNA) specific for human HO-1. In isolated primary chondrocytes, we determined senescence-associated β-galactosidase activity and the expression of senescence markers by real-time PCR. We have found that HO-1 induction could regulate senescence markers in the presence of IL-1β and significantly affected telomerase expression, as well as β-galactosidase activity and hTERT (human telomerase reverse transcriptase) and p21 expression in chondrocytes. The findings of the present study support the view that HO-1 induction results in the down-regulation of inflammatory and senescence responses in OA articular tissues.
A B S T R A C T IL (interleukin)-1β
plays an important role in cartilage extracellular matrix degradation and bone resorption in OA (osteoarthritis) through the induction of degradative enzymes and proinflammatory mediators. In the present study, we have determined the consequences of HO-1 (haem oxygenase-1) induction on markers of inflammation and senescence in the functional unit cartilage-subchondral bone stimulated with IL-1β. Cartilage-subchondral bone specimens were obtained from the knees of osteoarthritic patients. Treatment with the HO-1 inducer CoPP (cobalt protoporphyrin IX) counteracted the stimulatory effects of IL-1β on IL-6, nitrite, PGE 2 (prostaglandin E 2 ), TGF (transforming growth factor) β 2 , TGFβ 3 and osteocalcin. Immunohistochemical analyses indicated that CoPP treatment of explants downregulated iNOS (inducible nitric oxide synthase), COX-2 (cyclooxygenase-2) and mPGES-1 (microsomal prostaglandin E synthase-1) induced by IL-1β. In contrast, the expression of HMGB1 (high-mobility group box 1) was not significantly modified. In addition, CoPP decreased the expression of iNOS and mPGES-1 in cells isolated from the explants and stimulated with IL-1β, which was counteracted by an siRNA (small interfering RNA) specific for human HO-1. In isolated primary chondrocytes, we determined senescence-associated β-galactosidase activity and the expression of senescence markers by real-time PCR. We have found that HO-1 induction could regulate senescence markers in the presence of IL-1β and significantly affected telomerase expression, as well as β-galactosidase activity and hTERT (human telomerase reverse transcriptase) and p21 expression in chondrocytes. The findings of the present study support the view that HO-1 induction results in the down-regulation of inflammatory and senescence responses in OA articular tissues.
INTRODUCTION
OA (osteoarthritis) is characterized by the degradation of articular cartilage accompanied by subchondral bone sclerosis [1] . This disease involves an imbalance between catabolic and anabolic processes with loss of the chondrocyte ability to repair the cartilage matrix. In early OA, chondrocytes would be activated to proliferate and synthesize matrix molecules by growth factors, which could be more accessible to chondrocytes from the matrix or synovial fluid as a result of cartilage degradation [2] . In late OA, replicative and stress-induced senescence may contribute to the chronic pathology and progressive degeneration of cartilage [3] .
Pro-inflammatory cytokines play an important role in cartilage ECM (extracellular matrix) degradation [4] and bone resorption [5] . IL (interleukin)-1β and TNFα (tumour necrosis factor α) induce the production of NO and ROS (reactive oxygen species) by chondrocytes leading to deleterious effects [6] that may contribute to OA pathogenesis [7] . Pro-inflammatory cytokines generate a variety of mediators to control inflammatory reactions. Studies have demonstrated their ability to induce the translocation and release of nuclear DNAbinding protein HMGB1 (high-mobility group box 1) in different cell types (reviewed in [8] ) to act as a cytokine [9] or potentiate the pro-inflammatory activity of IL-1β [10] .
Growth factors promote the synthesis of ECM [11] and are central for the regulation of cartilage homoeostasis. Experimental evidence indicates that proinflammatory cytokines such as IL-1β down-regulate TGFβ (transforming growth factor β) and exert a suppressive effect on growth factor signalling in articular chondrocytes [12] .
Several studies have illustrated the potential importance of modulating IL-1 activity as a means to reduce the progression of the structural changes in OA [13] . It has been shown that pro-inflammatory mediators and oxidative stress are involved in premature stress-induced cellular senescence which leads to inhibition of telomerase activity [14] and articular aging [15] .
HO-1 (haem oxygenase-1) is induced as a protective response against cellular stress (reviewed in [16] ). The expression of this protein in OA chondrocytes is down-regulated by pro-inflammatory cytokines such as IL-1β, IL-17 and TNFα, but up-regulated by IL-10 [17] . In previous studies using chondrocytes from OA patients, we have demonstrated a protective role of HO-1 induction by CoPP (cobalt protoporphyrin IX) against the effects of IL-1β stimulation, with reductions in MMP (matrix metalloproteinases) and proteoglycan release from OA cartilage [18] .
Degenerative changes that occur during aging include the disruption of the articular cartilage surface, which contributes to OA initiation [19] . Nevertheless, OA is also associated with a thickening of subchondral plate and osteoblast dysfunction [20] , which may precede cartilage degradation [21] . Little is known of the interactions between articular cartilage and surrounding bone, although recent reports suggest that subchondral bone and articular cartilage form a functional unit with both mechanical and biochemical interactions [22] . Given the interest in novel therapies for articular degeneration, we characterized the effects of IL-1β on cartilage-subchondral bone explants from OA patients and explored the feasibility of using HO-1 induction as a protective strategy against degenerative changes in this functional unit.
MATERIALS AND METHODS

Explant culture
Osteochondral specimens were obtained from the knees of patients with diagnosis of advanced OA [15 females and seven males; age, 72 + − 7 years (value is the mean + − S.E.M.)] undergoing total knee joint replacement. Diagnosis was based on clinical, laboratory and radiological evaluation. All studies were performed under the University of Valencia and University Hospital Ethical Committees approved protocol and patients' consent according to the Declaration of Helsinki. Explants (including cartilage and subchondral bone) of 3.5 mm in diameter were dissected, transferred to 24-well plates (two to three explants from the same donor/well), and maintained for 24 h with DMEM (Dulbecco's modified Eagle's medium)/F12 (SigmaAldrich) supplemented with penicillin (100 units/ml) and streptomycin (100 μg/ml). Explants were cultured in the same medium supplemented with 10 % fetal bovine serum (Sigma-Aldrich) and stimulated with IL-1β (10 ng/ml) (Peprotech) and/or the HO-1 inducer CoPP (10 μM) (Frontier Scientific) for 72 h. These concentrations were selected as a result of previous studies [18] . Cellular viability was evaluated by the lactate dehydrogenase method. Treatments did not exert any significant effect on viability (97.0 + − 3.0, 101.3 + − 3.9 and 104.2 + − 2.7 % of non-stimulated explants for IL-1β, CoPP and IL-1β + CoPP respectively, n = 6). At the end of the experiment, the medium was separated by centrifugation and tissue explants were processed for histological and immunohistochemistry analyses.
Mediators released into the culture medium
Supernatants from explant cultures were used to measure PGE 2 (prostaglandin E 2 ) by RIA [23] and nitrite using a fluorimetric method [24] on a Victor3 microplate reader (PerkinElmer). IL-6 and osteocalcin were quantified by ELISAs from eBioscience (sensitivity of 2 pg/ml) and Bender MedSystems (sensitivity of 0.2 ng/ml) respectively. TGFβ 1 , TGFβ 2 and TGFβ 3 levels were measured by ELISAs from R&D Systems, with a sensitivity of 4.6, 7 and 20 pg/ml respectively.
Histological and immunohistochemistry analyses
For histology, explants were decalcified in 8 % formic acid and 10 % formaldehyde and subsequently dehydrated and embedded in paraffin. Tissue sections (5 μm) were mounted on SuperFrost slides (Menzel-Gläser), deparaffinized and stained with Masson trichromic stain. This differentiates cell nuclei, collagen fibres and osteoid matrix. For immunohistochemistry, slides were deparaffinized, rehydrated, treated with 2 % H 2 O 2 in methanol for 10 min at room temperature (25 • C) and incubated for 15 min with goat serum in PBS (1:10 dilution) (Sigma-Aldrich). Tissue sections were then incubated for 2 h with rabbit antibodies against COX-2 (cyclo-oxygenase-2), mPGES-1 (microsomal prostaglandin E synthase-1) and iNOS (inducible nitric oxide synthase) (Cayman Chemicals), HO-1 (Stressgene), HMGB1 (Upstate) and telomerase (AnaSpec). After rinsing, sections were incubated with the corresponding biotinylated secondary antibody (Dako) and processed using streptavidin-HRP (horseradish peroxidase; Dako). Development of the peroxidase staining was performed with diaminobenzidine (Vector Laboratories). Counterstaining was performed with haematoxylin/eosin and sections were mounted using Faramount aqueous mounting medium (Dako). Controls were done to determine the specificity of staining, with substitution of the primary antibodies with nonspecific rabbit IgG (Dako) at the same concentration as the primary antibody. Positive cells were counted by two independent observers. Each section was examined under a light microscope (Nikon Eclipse E800) and photographed with a Nikon Digital Camera DXM1200 using the software Nikon ACT-1.
Isolation and culture of chondrocytes
Cartilage samples from the OA patients indicated above were used for chondrocyte isolation by sequential enzymatic digestion: 1 h with 0.1 mg/ml hyaluronidase (Sigma-Aldrich), followed by 12 h with 1 mg/ml collagenase (type IA) (Sigma-Aldrich) at 37
• C in DMEM/Ham's F-12 (Sigma-Aldrich) containing penicillin (100 units/ml) and streptomycin (100 μg/ml) at 37
• C in 5% CO 2 atmosphere. The digested tissue was filtered through a 70 μm nylon mesh, washed and centrifuged. Cell viability was greater than 95 % according to the Trypan Blue exclusion test. The isolated chondrocytes were seeded at 2.5×10 5 cells/well in sixwell plates. Cells were cultured in DMEM/Ham's F-12 supplemented with 10 % human serum, penicillin (100 units/ml) and streptomycin (100 μg/ml) in a humidified 5 % CO 2 incubator at 37
• C. Chondrocytes in primary culture were allowed to grow until nearly confluence and then incubated with CoPP (10 μM) for 1 h before stimulation with IL-1β (10 ng/ml) for different times. Possible cytotoxicity of treatments was assessed by the mitochondria1-dependent reduction of MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide] to formazan. After appropriate stimulation, cells were incubated with MTT (200 μg/ml) for 2 h. The medium was then removed and the cells solubilized in DMSO (100 μl) to quantify formazan at 550 nm [25] .
Senescence-associated β-galactosidase activity assay
Senescence-associated β-galactosidase activity was measured using the cellular senescence assay kit from Cell Biolabs. Cells were counterstained with haematoxylin/eosin to count the total cell numbers. Chondrocytes were analysed using a Nikon Eclipse E800 microscope and photographed with a Nikon Digital Camera DXM1200 using the software Nikon ACT-1.
Real-time PCR
Total RNA from chondrocytes in primary culture was extracted using the TriPure reagent (Roche Applied Science). RT (reverse transcription) was accomplished on 1 μg of total RNA using random primers (TaqMan RT reagents; Applied Biosystems). PCRs were performed using SYBR Green PCR Master Mix (Bio-Rad Laboratories). Primers were from SA Biosciences. PCR assays were performed in duplicate on an iCycler RealTime PCR Detection System (Bio-Rad Laboratories) running the cycling conditions: 95
• C for 10 min, 40 cycles of 95
• C for 15 s and 60
• C for 1 min. Reaction specificity was determined by melting-curve analysis, which was performed by heating the plate from 55 to 95
• C and measuring SYBR Green I dissociation from the amplicons. C T (cycle threshold) values for each gene were corrected using the mean C T value for β-actin. Relative gene expression was calculated using the C T method and expressed as fold change (2 − C T ) relative to the expression values in non-stimulated cells [26] .
Western blot analysis
Cells present in explants (including cartilage and subchondral bone) were isolated by sequential enzymatic digestion and cultured as indicated above. Cell viability was greater than 95 % according to the Trypan Blue exclusion test. The isolated cells were seeded at (3-4) ×10 5 cells/well in six-well plates. Cells were cultured in growth medium: DMEM/Ham's F-12 supplemented with 10 % human serum, penicillin (100 units/ml) and streptomycin (100 mg/ml) in a humidified 5 % CO 2 incubator at 37
• C. Cells in primary culture were allowed to grow until nearly confluence and then treated for 72 h with IL-1β (10 ng/ml) or IL-1β + CoPP (10 μM) in the presence or absence of siRNA (small interfering RNA; 100 nM) specific for human HO-1 (sense 5 -GGCAGAGAAUGCUGAGUUCtt-3 , antisense 5 -GAACUCAGCAUUCUCUGCCtg-3 ) and a non-specific siRNA was used as negative control. Both were transfected in SiPORT TM Amine, following the manufacturer's recommendations (Ambion), 24 h before other experimental procedures. Cells were lysed in 100 μl of buffer (1 % Triton X-100, 1 % deoxycholic acid, 20 mM NaCl and 25 mM Tris/HCl, pH 7.4) and centrifuged at 4
• C for 10 min at 10 000 g. Protein content was determined by the DC Bio-Rad Laboratories protein reagent. Proteins (25 μg) in supernatants were separated by SDS/PAGE (12.5 % gel) and transferred on to PVDF membranes. Membranes were blocked with 3 % BSA and incubated with specific polyclonal antibodies against iNOS, COX-2 and mPGES-1 (Cayman Chemicals), HO-1 (Stressgene), telomerase (AnaSpec) and β-actin (Sigma-Aldrich) for 2 h at room temperature. Finally, membranes were incubated with peroxidase-conjugated goat anti-rabbit IgG (Dako) and the immunoreactive bands were visualized by ECL ® (enhanced chemiluminescence; GE Healthcare) using an AutoChemi image analyser (UVP).
Statistical analysis
The results were analysed using a Kruskal-Wallis test and a Dunn's post-hoc test using the GraphPad Prism 4 software (Graph Pad Software). A P < 0.05 was considered to indicate statistical significance.
RESULTS
Cartilage-subchondral bone explants
Explants used in the present study included cartilage and subchondral bone. Figure 1 shows a representative explant section including SZ (superficial zone), TZ (transitional zone, RZ (radial zone), CZ (calcified zone) and SC (subchondral zone). For immunohistochemistry analyses, two main areas were distinguished in tissue sections: cartilage containing SZ, TZ and RZ, and OS (osteochondral area) containing CZ and SC.
Influence of IL-1β and CoPP on the release of mediators into the culture medium
To investigate the effects of the pro-inflammatory cytokine IL-1β and the consequences of HO-1 induction on the production of mediators relevant in inflammatory responses and cell metabolism, explants were cultured with this cytokine in the presence or absence of the HO-1 inducer CoPP and the levels of different mediators were determined in the culture medium. First, we examined the time course of explant stimulation with IL-1β. Figures 2(A)-2(C) show the effects of this cytokine on the accumulation of nitrite (an index of NO), PGE 2 and IL-6 in the culture medium. We observed maximal levels of these inflammatory mediators after incubation of explants for 72 h (Figure 2) , and therefore this time point was chosen to study the effects of CoPP. Figures 3(A) -3(C) show that the strong stimulatory effects of IL-1β on the production of nitrite, PGE 2 and IL-6 were counteracted by CoPP treatment of explants. In contrast, IL-1β reduced the production of osteocalcin ( Figure 3D ), TGFβ 1 , TGFβ 2 and TGFβ 3 ( Figure 4 ). These effects of IL-1β were significantly reversed by CoPP treatment of explants, except for TGFβ 1 .
Immunohistochemical analysis of HO-1, iNOS, COX-2, mPGES-1 and HMGB1 expression in explants
We determined the expression of HO-1 protein in explant sections by immunohistochemistry. As shown in Figure 5 (A), a high level of HO-1 expression was observed in non-stimulated explants and, consistent with our previous results in OA chondrocytes [17] , incubation with IL-1β (10 ng/ml) for 72 h significantly reduced To gain insight into the mechanisms involved in the effects of CoPP on NO and PGE 2 , we studied in explant sections the expression of relevant proteins. Our results indicate that iNOS expression was almost absent in nonstimulated explants ( Figure 5B ). After stimulation with IL-1β, iNOS was strongly induced only in cartilage and CoPP treatment significantly reduced the expression of this protein. COX-2 was expressed in non-stimulated explants mainly in cartilage ( Figure 6A ), and was induced by IL-1β in both areas, with statistical significance in OS. CoPP significantly decreased the expression of COX-2 stimulated by IL-1β in cartilage and osteochondral zones. Explants were incubated for 72 h in the presence or absence of IL-1β (10 ng/ml) and CoPP (10 μM). Explants from six to eight donors were evaluated in 6-8 separate experiments. Nitrite was determined using a fluorimetric procedure, PGE 2 was determined by RIA, and IL-6 and osteocalcin were determined by ELISA. Bars represent median values.
In addition, mPGES-1 expression was induced by IL-1β in both areas of explants whereas CoPP treatment in the presence of this cytokine significantly reduced it ( Figure 6B ).
We also studied the expression of HMGB1 in explant sections. This protein is released by necrotic cells and secreted after stimulation with pro-inflammatory cytokines (reviewed in [8] ). HMGB1 was present in nonstimulated explants mainly in cartilage, and its expression was increased by IL-1β in OS. Explant treatment with 
Influence of IL-1β and CoPP on senescence markers
Chondrocyte senescence is strongly related to cartilage degeneration. Senescence features such as β-galactosidase expression, reduced matrix production and cellular proliferation, and telomerase activity have been shown in OA chondrocytes [27, 28] . Figure 7 (A) shows that telomerase expression was significantly decreased by IL-1β in the whole explant, while CoPP significantly reversed the effects of cytokine stimulation in cartilage. To confirm possible effects of CoPP on cell senescence in cartilage, we quantified senescence-associated β-galactosidase activity in a primary culture of OA chondrocytes. As shown in Figure 7 (B), IL-1β treatment significantly increased this enzyme activity and CoPP strongly reduced the effects of this pro-inflammatory cytokine. Our results also indicate that CoPP augmented mRNA expression of hTERT (human telomerase reverse transcriptase) in chondrocytes incubated with IL-1β ( Figure 7C ), whereas the mRNA of the senescence marker p21, was significantly down-regulated by CoPP in the presence of IL-1β.
Protein expression in cells isolated from explants
In addition to immunohistochemical analyses, protein expression was studied by Western blotting and we used an siRNA specific for human HO-1 to assess that CoPP effects were dependent on HO-1 induction. For this purpose, cells were isolated from explants and treated for 72 h with IL-1β (10 ng/ml) or IL-1β + CoPP (10 μM) in the presence or absence of HO-1 siRNA or a nonspecific siRNA (control siRNA). Figure 8 shows the strong induction of HO-1 by CoPP treatment which was lower in the presence of IL-1β. HO-1 expression was inhibited by HO-1 siRNA but not by the control siRNA. These experiments in isolated cells confirmed the results obtained for iNOS and telomerase expression in explants. However, COX-2 expression induced by IL-1β was not modified by CoPP although the levels of PGE 2 in the culture medium were reduced by this treatment (64.5 + − 8.9 ng/mg of protein in cells treated with IL-1β + CoPP compared with 99.5 + − 4.7 ng/mg of protein in cells treated with IL-1β, n = 3, P < 0.01). To further characterize the mechanisms involved in the inhibitory effects of CoPP on PGE 2 production, we studied the expression of another enzyme involved in the production of this eicosanoid, mPGES-1. IL-1β treatment resulted in the strong induction of this protein which was inhibited by CoPP. The effects of CoPP on protein expression were counteracted in cells treated with HO-1 siRNA.
DISCUSSION
Morphological changes observed in OA include cartilage erosion as well as a variable degree of synovial inflammation. Current research attributes these changes to a complex network of biochemical factors, including proteolytic enzymes that lead to a breakdown of the cartilage macromolecules. Cytokines such as IL-1 and TNFα are the predominant pro-inflammatory cytokines synthesized during the OA process [29] by activated synoviocytes, mononuclear cells or by articular cartilage itself leading to the up-regulation of inflammatory and catabolic mediators. Cytokines also blunt chondrocyte compensatory synthesis pathways required to restore the integrity of the degraded ECM [13] .
In the present study, we have shown that HO-1 protein is present in cells of all areas of OA Explants were incubated for 72 h in the presence or absence of IL-1β (10 ng/ml) and CoPP (10 μM). Explants from seven donors were evaluated in 6-7 separate experiments. C, cartilage; OS, osteochondral area; B, non-stimulated explants. Scale bar = 50 μm. Bars represent median values.
cartilage-subchondral bone explants, and mainly in chondrocytes of the SZ of cartilage. Increasing evidence supports the relevance of this zone of articular cartilage in maintaining tissue function and homoeostasis [30] . A marked increase in basal HO-1 expression was evident in cultured explant-derived cells after CoPP treatment, which was in agreement with our previous work in OA chondrocytes [17] . In contrast, we observed no detectable We have also demonstrated that IL-1β down-regulates HO-1, which is in line with our previous data showing the negative effects of IL-1β on HO-1 expression in OA chondrocytes [17] . CoPP treatment significantly prevented the down-regulation of HO-1 expression induced by this cytokine in cartilage-subchondral bone explants. In addition, HO-1 induction by CoPP resulted in the inhibition of IL-6 and PGE 2 levels induced by IL-1β.
NO overproduction by articular chondrocytes may be involved in the aetiopathogenesis of OA. Endogenously produced NO would act locally within the cartilage to inhibit matrix synthesis [32] . Experimental evidence indicates that the inhibition of NO production results in a marked decrease in major catabolic factors such as MMPs, IL-1β and peroxynitrite and reduced COX-2 expression [33] . In the present study, we have demonstrated that CoPP treatment is an effective strategy to down-regulate iNOS and NO production induced by IL-1β in the OA cartilage. We have shown previously that HO-1 induction by CoPP results in the inhibition of NF-κB (nuclear factor κB) in OA chondrocytes stimulated with IL-1β [34] . This mechanism could be responsible for the observed down-regulation of iNOS as NF-κB plays a key role in the transcription of this gene after IL-1β stimulation [35] .
We have observed an inhibitory effect of CoPP on the production of PGE 2 stimulated by IL-1β in whole explants and isolated cells. Our results indicate that a reduction in mPGES-1 expression could be responsible for this effect. In addition, we have observed the down-regulation of COX-2 expression by CoPP in explants stimulated with IL-1β but not in isolated cells in culture and thus this mechanism may participate in the reduction of PGE 2 levels in explants after CoPP treatment, which was stronger (67.6 % inhibition) than in isolated cells (35.2 % inhibition). Explants and monolayer cell cultures represent different experimental conditions, as the cartilage-subchondral bone explant is a complex system including different cell types in a threedimensional matrix, with many possible cell-cell and cellmatrix interactions that may influence cell metabolism and protein expression. In fact, biochemical interactions between cartilage and subchondral bone may be involved in joint degradation [22] .
The production of PGE 2 supports osteoclast formation and has been related to inflammatory bone resorption [36] . We have observed in explants that IL-1β decreased osteocalcin levels as well as increased the expression of COX-2 in the OS. Both effects were significantly counteracted by CoPP and therefore our results suggest that this treatment protects osteoblasts against the negative effects of IL-1β.
Our results have shown that HMGB1 is strongly expressed in the SZ of cartilage, although induction by IL-1β is mainly observed in the OS. In addition to a possible role in endochondral ossification during osteogenesis [37] , HMGB1 may activate OA chondrocytes resulting in the phosphorylation of extracellular signal-regulated kinase and NF-κB, and increased MMP expression [38] . It is also known that extracellular HMGB1 acts as a pro-inflammatory cytokine in synovial tissues [39] . We have recently shown that HO-1 down-regulates HMGB1 in OA synoviocytes [40] . Nevertheless, in the present study, HO-1 induction by CoPP did not modify HMGB1 expression, suggesting a more prominent role of HO-1 for HMGB1 modulation in synoviocytes.
Animal experiments suggest that a lack of responsiveness to TGFβ may be involved in OA development [41] , while the addition of TGFβ 2 to OA cartilage explants results in inhibitory effects on MMP expression and collagen resorption [42] . We have shown an inhibitory effect of IL-1β on TGFβ 1, TGFβ 2 and TGFβ 3 production in cartilage-subchondral bone explants, which was counteracted by CoPP treatment for the last two proteins. Our results thus suggest that the protective effects of HO-1 induction on ECM metabolism may be in part related to the ability of HO-1 to regulate these growth factors.
Chondrocyte senescence contributes to the age-related increase in the prevalence of OA and decrease in the efficacy of cartilage repair [3] . Stress factors such as ROS and IL-1β induce premature senescence of chondrocytes [43] . Free radical scavengers may protect articular cartilage against progression of OA through the inhibition of MMPs, apoptosis and premature senescence in chondrocytes [44] . There is an important relationship between chondrocyte senescence and telomerase activity [45] . Interestingly, our results show that HO-1 induction counteracts the effects of IL-1β on the expression of senescence markers such as telomerase, hTERT and p21, as well as on senescence-associated β-galactosidase activity. These effects would result in protection against premature cellular senescence and the progression of OA articular changes, and may be related to the inhibitory effects of HO-1 on oxidative stress [34] and NO generation.
In conclusion, the cartilage-subchondral bone explant culture represents an integrative approach to study articular metabolism and cellular interactions. Our findings in this experimental system confirm previous data in OA chondrocytes and reveal novel protective effects of HO-1 induction on the production of NO, IL-6, TGFβ, osteocalcin and cellular senescence markers. Therefore HO-1 up-regulation counteracts the detrimental effects of IL-1β on cartilage and subchondral bone in OA.
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Figure S1 HMGB1 immunohistochemical evaluation in sections of cartilage-subchondral bone explants from OA patients
Explants were incubated for 72 h in the presence or absence of IL-1β (10 ng/ml) and CoPP (10 μM). Explants from six donors were evaluated in six separate experiments. Scale bar, 50 μm. Bars represent median values. C, cartilage; OS, osteochondral area; B, non-stimulated explants.
